Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06378190
Title Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology (TranspoCART19)
Acronym TranspoCART19
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Instituto de Investigacion Biomedica de Salamanca
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Institut Català d'Oncologia Hospital NOT_YET_RECRUITING Hospitalet de Llobregat Barcelona Spain Details
Virgen de la Arrixaca University Hospital NOT_YET_RECRUITING El Palmar Mur Spain Details
Clínica Universidad de Navarra RECRUITING Pamplona Navarra 31008 Spain Details
University Hospital of Navarra NOT_YET_RECRUITING Pamplona Navarra Spain Details
Hospital Clínic NOT_YET_RECRUITING Barcelona Spain Details
Fundación Jiménez Díaz Hospital NOT_YET_RECRUITING Madrid Spain Details
Salamanca University Health Care Complex RECRUITING Salamanca 37007 Spain Details
Virgen del Rocio Hospital NOT_YET_RECRUITING Sevilla Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field